AVO vs CVAT
Mission Produce, Inc. and Cavitation Technologies, Inc., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | AVO | CVAT |
|---|---|---|
| Revenue | $1.4B | $203,000 |
| Net income | $37.7M | $-113,000 |
| Gross margin | 11.6% | 81.3% |
| Net margin | 2.7% | −55.7% |
| Return on equity | 6.6% | −3487.2% |
| Diluted EPS | $0.53 | $0.00 |
| Dividend / share | $0.21 | — |
| Payout ratio | −0.0% | — |
| Free cash flow | $37.2M | $-378,000 |
| Equity | $587.3M | $69,000 |
| Net debt / equity | 0.05× | −1.78× |
| Current ratio | 1.95× | 2.80× |
| Revenue CAGR 5y | 10.0% | −34.3% |
| Profit CAGR 5y | 5.5% | — |
AVO bills 6853.2× the revenue of CVAT, and CVAT closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
6 years side by side
| Fiscal year | AVO | CVAT |
|---|---|---|
| FY2024 | $1.2B | $203,000 |
| FY2023 | $953.9M | $1.4M |
| FY2022 | $1.0B | $433,000 |
| FY2021 | $891.7M | $1.6M |
| FY2020 | $862.3M | $537,000 |
| FY2019 | $883.3M | $1.7M |
Net income by year
Bottom line
| Fiscal year | AVO | CVAT |
|---|---|---|
| FY2024 | $36.7M | $-113,000 |
| FY2023 | $-2.8M | $439,000 |
| FY2022 | $-34.6M | $-2.0M |
| FY2021 | $44.9M | $-619,000 |
| FY2020 | $28.8M | $-649,000 |
| FY2019 | $71.7M | $128,000 |
Advertisement
AdSense · Rectangle 336×280